Abstract
This study focused on developing a gastroretentive drug delivery system employing a triple-mechanism interpolyelectrolyte complex (IPEC) matrix comprising high density, swelling, and bioadhesiveness for the enhanced site-specific zero-order delivery of levodopa in Parkinson’s disease. An IPEC was synthesized and directly compressed into a levodopa-loaded matrix employing pharmaceutical technology and evaluated with respect to its physicochemical and physicomechanical properties and in vitro drug release. The IPEC-based matrix displayed superior mechanical properties in terms of matrix hardness (34–39 N/mm) and matrix resilience (44–47%) when different normality’s of solvent and blending ratios were employed. Fourier transform infrared spectroscopy confirmed the formation of the IPEC. The formulations exhibited pH and density dependence with desirable gastro-adhesion with Peak Force of Adhesion ranging between 0.15 and 0.21 N/mm, densities from 1.43 to 1.54 g/cm3 and swellability values of 177–234%. The IPEC-based gastroretentive matrix was capable of providing site-specific levodopa release with zero-order kinetics corroborated by detailed mathematical and molecular modeling studies. Overall, results from this study have shown that the IPEC-based matrix has the potential to improve the absorption and subsequent bioavailability of narrow absorption window drugs, such as levodopa with constant and sustained drug delivery.
Similar content being viewed by others
REFERENCES
Birkmayer W, Hornykiewicz O. Der l-3,4-dioxyphenylalanin (=DOPA)-Effekt bei Parkinson-Akinese. Wien Klin Wochenschr. 1961;73:787–8.
Muzzi C, Bertocci E, Terzuoli L, Porcelli B, Ciari I, Pagani R, et al. Simultaneous determination of serum concentrations of levodopa, dopamine, 3-O-methyldopa and α-methyldopa by HPLC. Biomed Pharmacother. 2008;62:253–8.
Jankovic J. Levodopa strengths and weaknesses. Neurology. 2002;58:S19–32.
Sagar KA, Smyth MR. Bioavailability studies of oral dosage forms containing levodopa and carbidopa using column-switching chromatography followed by electrochemical detection. Analyst. 2000;125:439–45.
Koller WC, Hutton JT, Tolosa E, Capilldeo R. Immediate-release and controlled-release carbidopa/levodopa in PD: a 5-year randomized multicenter study. Neurology. 1999;53:1012.
Ngwuluka N, Pillay V, Du Toit LC, Ndesendo V, Choonara Y, Modi G, et al. Levodopa delivery systems: advancements in delivery of the gold standard. Expert Opin Drug Deliv. 2010;7:203–24.
Arza R, Gonugunta C, Veerareddy P. Formulation and evaluation of swellable and floating gastroretentive ciprofloxacin hydrochloride tablets. AAPS PharmSciTech. 2009;10:220–6.
Klausner EA, Eyal S, Lavy E, Friedman M, Hoffman A. Novel levodopa gastroretentive dosage form: in-vivo evaluation in dogs. J Control Release. 2003;88:117–26.
Goole J, Vanderbist F, Amighi K. Development and evaluation of new multiple-unit levodopa sustained-release floating dosage forms. Int J Pharm. 2007;334:35–41.
Goole J, Deleuze P, Vanderbist F, Amighi K. New levodopa sustained-release floating minitablets coated with insoluble acrylic polymer. Eur J Pharm Biopharm. 2008;68:310–8.
Kumar P, Pillay V, Choonara YE, Modi G, Naidoo D, du Toit LC. In Silico theoretical molecular modeling for Alzheimer’s disease: the nicotine-curcumin paradigm in neuroprotection and neurotherapy. Int J Mol Sci. 2011;12:694–724.
Camacho MM, Martínez-Navarrete N, Chiralt A. Rheological characterization of experimental dairy creams formulated with locust bean gum (LBG) and λ-carrageenan combinations. Int Dairy J. 2005;15:243–8.
Sittikijyothin W, Torres D, Gonçalves MP. Modelling the rheological behaviour of galactomannan aqueous solutions. Carbohydr Polym. 2005;59:339–50.
Bardonnet PL, Faivre V, Pugh WJ, Piffaretti JC, Falson F. Gastroretentive dosage forms: overview and special case of Helicobacter pylori. J Control Release. 2006;111:1–18.
Chawla G, Gupta P, Koradia V, Bansal AK. Gastroretention: a means to address regional variability in intestinal drug absorption. Pharm Technol. 2003;27:50–68.
Davis SS, Hardy JG, Fara JW. Transit of pharmaceutical dosage forms through the small intestine. Gut. 1986;27:886–92.
Nur A, Zhang J. Captopril floating and/or bioadhesive tablets: design and release kinetics. Drug Dev Ind Pharm. 2000;26:965.
Lee JW, Park JH, Robinson JR. Bioadhesive-based dosage forms: the next generation. J Pharm Sci. 2000;89:850–66.
Thirawong N, Kennedy RA, Sriamornsak P. Viscometric study of pectin–mucin interaction and its mucoadhesive bond strength. Carbohydr Polym. 2008;71:170–9.
Vasir JK, Tambwekar K, Garg S. Bioadhesive microspheres as a controlled drug delivery system. Int J Pharm. 2003;255:13–32.
O’Brien S, Wang Y, Vervaet C, Remon JP. Starch phosphates prepared by reactive extrusion as a sustained release agent. Carbohydr Polym. 2009;76:557–66.
Kim SW, Bae YH, Okano T. Hydrogels: swelling, drug loading, and release. Pharm Res. 1992;9:283–90.
Wise DL, Trantolo DJ, Altobelli DE, Yaszemski MJ, Gresser JD, Schwartz ER. Encyclopedic handbook of biomaterials and bioengineering. 1st ed. Sheffield: Marcel Dekker; 1995. p. 3760.
Siepmann J, Göpferich A. Mathematical modeling of bioerodible, polymeric drug delivery systems. Adv Drug Deliv Rev. 2001;48:229–47.
Faisant N, Siepmann J, Benoit JP. PLGA-based microparticles: elucidation of mechanisms and a new, simple mathematical model quantifying drug release. Eur J Pharm Sci. 2002;15:355–66.
Merchant H, Shoaib H, Tazeen J, Yousuf R. Once-daily tablet formulation and in vitro release evaluation of cefpodoxime using hydroxypropyl methylcellulose: a technical note. AAPS PharmSciTech. 2006;7:E178–83.
Sriamornsak P, Thirawong N, Weerapol Y, Nunthanid J, Sungthongjeen S. Swelling and erosion of pectin matrix tablets and their impact on drug release behavior. Eur J Pharm Biopharm. 2007;67:211–9.
Greaves JL, Wilson CG. Treatment of diseases of the eye with mucoadhesive delivery systems. Adv Drug Deliv Rev. 1993;11:349–83.
Jelinek M, Cristescu R, Axente E, Kocourek T, Dybal J, Remsa J, et al. Matrix assisted pulsed laser evaporation of cinnamate-pullulan and tosylate-pullulan polysaccharide derivative thin films for pharmaceutical applications. Appl Surf Sci. 2007;253:7755–60.
Abou-Rachid H, Lussier L, Ringuette S, Lafleur-Lambert X, Jaidann M, Brisson J. On the correlation between miscibility and solubility properties of energetic plasticizers/polymer blends: modeling and simulation studies. Propell Explos Pyrot. 2008;33:301–10.
Murphy C, Pillay V, Choonara Y, du Toit L, Ndesendo V, Chirwa N, et al. Optimization of a dual mechanism gastrofloatable and gastroadhesive delivery system for narrow absorption window drugs. AAPS PharmSciTech. 2012;13(1):1–15.
Kumar P, Bhatia M. Functionalization of chitosan/methylcellulose interpenetrating polymer network microspheres for gastroretentive application using central composite design. PDA J Pharm Sci Technol. 2010;64:497–506.
Kumar P, Singh I. Formulation and characterization of tramadol-loaded IPN microgels of alginate and gelatin: optimization using response surface methodology. Acta Pharm. 2010;60:295–310.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ngwuluka, N.C., Choonara, Y.E., Modi, G. et al. Design of an Interpolyelectrolyte Gastroretentive Matrix for the Site-Specific Zero-Order Delivery of Levodopa in Parkinson’s Disease. AAPS PharmSciTech 14, 605–619 (2013). https://doi.org/10.1208/s12249-013-9945-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1208/s12249-013-9945-1